Facial basal cell carcinomas recurring after photodynamic therapy: a retrospective analysis of histological subtypes
- PMID: 22759732
- DOI: 10.1159/000339335
Facial basal cell carcinomas recurring after photodynamic therapy: a retrospective analysis of histological subtypes
Abstract
Background: Photodynamic therapy (PDT) is an established treatment for basal cell carcinomas (BCCs). Although recurrences are sometime observed, their histological patterns have never been specifically studied or compared with the one of the initial tumor.
Objective: To compare the histopathological aggressiveness of BCCs recurring after PDT with that of the primary tumors.
Methods: The study population included 12 patients with 16 post PDT recurrent BCCs. Outcome measures were proportion of histologically aggressive subtypes in BCC recurrences vs. primary tumor.
Results: 62.5% of recurrent BCCs displayed a transition from a non-aggressive to an aggressive subtype.
Conclusions: Post PDT recurrences appear to display an increased histological aggressiveness, although the latter may reflect the natural course of tumor progression. Despite the presence of potential biases, our study raises the possibility that PDT favors the selection of more aggressive tumor cells. Better systematic large-scale follow-up studies are required to assess the exact frequency and histological types of BCC recurrences after PDT.
Copyright © 2012 S. Karger AG, Basel.
Comment in
-
Facial basal cell carcinomas recurring after imiquimod therapy.Dermatology. 2013;226(1):13-4. doi: 10.1159/000345763. Epub 2012 Dec 28. Dermatology. 2013. PMID: 23296025 No abstract available.
-
Response to the possibility of the application of topical photodynamic therapy leading to development of more histologically aggressive subtypes of Basal cell carcinomas.J Drugs Dermatol. 2014 Mar;13(3):241-2. J Drugs Dermatol. 2014. PMID: 24595565 No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical

